Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | F2 | P00734 | 1/20 | 0.32 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.32 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.32 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP9 | P14780 | 1/20 | 0.31 |
| ▸ | MMP8 | P22894 | 1/20 | 0.31 |
| ▸ | MMP13 | P45452 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL344486 | 1.00 | LMNA (0.44) | LMNATHRBCA2F2PRSS1 | |
| SCHEMBL345309 | 1.00 | LMNA (0.44) | LMNATHRBCA2F2PRSS1 | |
| SCHEMBL394687 | 1.00 | LMNA (0.44) | LMNATHRBCA2F2PRSS1 | |
| SCHEMBL397274 | 1.00 | LMNA (0.44) | LMNATHRBCA2F2PRSS1 | |
| SCHEMBL637823 | 1.00 | LMNA (0.44) | LMNATHRBCA2F2PRSS1 | |
| SCHEMBL394637 | 1.00 | LMNA (0.44) | LMNATHRBCA2F2PRSS1 | |
| SCHEMBL396607 | 1.00 | LMNA (0.44) | LMNATHRBCA2F2PRSS1 | |
| SCHEMBL4350577 | 1.00 | LMNA (0.44) | LMNATHRBCA2F2PRSS1 | |
| SCHEMBL394884 | 1.00 | LMNA (0.44) | LMNATHRBCA2F2PRSS1 | |
| SCHEMBL2050322 | 1.00 | LMNA (0.44) | LMNATHRBCA2F2PRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111763704-A | Method for improving yield and thallus density of semaglutide precursor | 济南康和医药科技有限公司 | 2020-10-13 | — | — | CN | claimed |
| CN-111763704-A | Method for improving yield and thallus density of semaglutide precursor | 济南康和医药科技有限公司 | 2020-10-13 | — | — | CN | disclosed |
| EP-1307236-A2 | USE OF METAL COMPLEXES CONTAINING PERFLUOROALKYL AS CONTRAST AGENTS IN MR-IMAGING FOR THE REPRESENTATION OF PLAQUES, TUMOURS AND NECROSES | SCHERING AKTIENGESELLSCHAFT (DE) | 2003-05-07 | — | — | EP | disclosed |
| WO-2002013874-A2 | USE OF METAL COMPLEXES CONTAINING PERFLUOROALKYL AS CONTRAST AGENTS IN MR-IMAGING FOR THE REPRESENTATION OF PLAQUES, TUMOURS AND NECROSES | SCHERING AKTIENGESELLSCHAFT (DE) | 2002-02-21 | — | — | WO | disclosed |